StockData
OS Therapies Inc logo

OS Therapies Inc (OSTX) stock

OSTXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.82−0.10 (-10.82%)

Close on Nov 19, 2026Market cap $37.84MP/E –Yield –

OS Therapies gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for OS Therapies

OS Therapies has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More OS Therapies figures

See a number that looks wrong?